Follow
Zhan Di
Zhan Di
NYU School of Medicine
Verified email at nyumc.org
Title
Cited by
Cited by
Year
SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia
J Bu, A Chen, X Yan, F He, Y Dong, Y Zhou, J He, D Zhan, P Lin, ...
Leukemia 32 (4), 890-899, 2018
352018
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
Y Dong, X Zhao, X Feng, Y Zhou, X Yan, Y Zhang, J Bu, D Zhan, ...
Leukemia 33 (11), 2585-2598, 2019
332019
The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes
P Lin, Y Ren, X Yan, Y Luo, H Zhang, M Kesarwani, J Bu, D Zhan, Y Zhou, ...
haematologica 104 (3), 485, 2019
302019
Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia
D Zhan, Y Zhang, P Xiao, X Zheng, M Ruan, J Zhang, A Chen, Y Zou, ...
Leukemia research 65, 20-24, 2018
262018
Tumor microenvironment–derived R-spondins enhance antitumor immunity to suppress tumor growth and sensitize for immune checkpoint blockade therapy
Y Tang, Q Xu, L Hu, X Yan, X Feng, A Yokota, W Wang, D Zhan, ...
Cancer discovery 11 (12), 3142-3157, 2021
162021
The system can't perform the operation now. Try again later.
Articles 1–5